Ultrasound Needle Guides Market Size - By Type (Disposable Needle Guides, Reusable Needle Guides), By Application (Tissue Biopsy, Fluid Aspiration, Vascular Access Procedures, Nerve Block and Regional Anesthesia), By End-use – Global Forecast 2023-2032

Ultrasound Needle Guides Market Size - By Type (Disposable Needle Guides, Reusable Needle Guides), By Application (Tissue Biopsy, Fluid Aspiration, Vascular Access Procedures, Nerve Block and Regional Anesthesia), By End-use – Global Forecast 2023-2032

Ultrasound Needle Guides Market Size

Ultrasound Needle Guides Market size was valued at USD 272.5 million in 2022 and is estimated to account for USD 461.9 million by 2032 owing to growing preference for minimally invasive biopsies.
 

The ultrasound needle guides market encompasses the development, manufacturing, and distribution of devices or systems used to assist healthcare professionals in accurately guiding biopsy needles during ultrasound-guided procedures. These guides enhance the accuracy and safety of biopsies by providing a predefined pathway for needle insertion. The market is driven by the continuous advancements in ultrasound imaging technology that improved the quality and resolution of images, enabling precise visualization of anatomical structures and needle placement. Advanced ultrasound systems with features like real-time imaging, 3D/4D imaging, and fusion imaging have enhanced the efficiency and safety of ultrasound-guided procedures, driving the adoption of needle guides.
 

The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and organ-related conditions needs accurate diagnostic techniques such as biopsies thereby stimulating product adoption rate. For instance, according to the American Cancer Society’s projections, more than 1,958,310 new cancer cases and 609,820 cancer-related deaths in the U.S. will occur in 2023. Furthermore, the World Health Organization (WHO) states that cardiovascular diseases (CVDs) are the primary cause of death globally, claiming approximately 17.9 million lives annually. Among these deaths, more than four out of five are attributed to heart attacks and strokes, with one-third occurring prematurely in individuals under the age of 70. As, the prevalence of these diseases continues to rise, there is a growing demand for efficient and precise biopsy procedures, leading to increased adoption of ultrasound-guided biopsies and subsequently driving the demand for ultrasound needle guides.
 

Additionally, ultrasound imaging is gaining widespread adoption as a diagnostic tool for various medical procedures, including biopsies. Ultrasound-guided biopsies provide real-time visualization of the target area, allowing healthcare providers to precisely locate and sample tissues or cells of interest. Therefore, these driving factors highlight the industry's focus on improving diagnostic accuracy, patient experience, and procedural outcomes. With continuous advancements in technology and a growing emphasis on precise tissue diagnostics, the ultrasound needle guides market is estimated to witness sustained growth in the projected years.
 

COVID-19 Impact

The COVID-19 pandemic initially had a negative impact on the ultrasound needle guides market, leading to a decline in demand due to delayed and cancelled procedures. However, as the situation progressed, the market experienced a boost. For instance, the increased focus on non-invasive procedures, driven by the contagious nature of the virus, created an opportunity for ultrasound-guided biopsies and subsequently, ultrasound needle guides.
 

Furthermore, the accelerated adoption of telemedicine opened avenues for remote guidance of procedures, potentially increasing the utilization of ultrasound needle guides. Moreover, the heightened emphasis on infection control measures highlighted the importance of sterile and single-use devices like needle guides, driving their demand. As healthcare services recovered and adapted to the changing landscape, the market for ultrasound needle guides regained momentum and catered to the need for accurate and minimally invasive biopsy procedures.

Ultrasound Needle Guides Market Trends

Minimally invasive procedures gained significant popularity in the field of medicine due to several advantages over traditional open surgeries. These procedures involve smaller incisions, reduced trauma to the patient's body, shorter recovery times, and decreased risks of complications. As a result, patients and healthcare providers are increasingly opting for minimally invasive approaches. This preference drives the market for ultrasound needle guides as an essential tool in ensuring accurate and safe biopsy procedures. Additionally, minimally invasive procedures can be cost-effective for healthcare systems. Thus, considering these factors, the demand for minimally invasive procedures, including ultrasound-guided needle procedures, is predicted to continue rising lucratively in the near future.
 

Ultrasound Needle Guides Market Analysis

The ultrasound needle guides market by type is categorized into disposable needle guides, and reusable needle guides. The disposable needle guides segment garnered USD 183.3 million revenue size in the year 2022. Disposable needle guides provide convenience and efficiency by eliminating the need for cleaning and sterilization, streamlining workflow, and saving time. Improved infection control is achieved through their single-use nature, reducing the risk of cross-contamination and infections. Furthermore, suitability for point-of-care settings, with simplified setup and ease of use, makes them ideal for clinics and smaller healthcare facilities.
 

Overall, the demand for disposable needle guides is driven by their convenience, improved infection control, cost-effectiveness, regulatory compliance, and suitability for various healthcare settings. Therefore, disposable needle guides are a pivotal driving factor in the market, offering various advantages and propelling the market trends.
 

Based on application, the ultrasound needle guides market is segmented into tissue biopsy, fluid aspiration, vascular access procedures, nerve block and regional anaesthesia, and others. The tissue biopsy segment accounted for 37% revenue share in the year 2022 and is anticipated to witness highest growth during the forecast period. The use of needle guides in ultrasound-guided tissue biopsies offers enhanced accuracy and precision, ensuring precise sampling of the target tissue. The preference for minimally invasive procedures, expanding accessibility in diverse clinical settings, and the increasing prevalence of target diseases contribute to the demand for ultrasound-guided tissue biopsies and needle guides.
 

Furthermore, technological advancements in ultrasound imaging improve the effectiveness and precision of the biopsy procedure, making ultrasound-guided biopsies a preferred choice for tissue sampling. These factors collectively drive the growth of the market in the tissue biopsy application segment.
 

Based on end-use, the ultrasound needle guides market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals and clinics segment accounted for over 64.4% business share in the year 2022 and is anticipated to witness the highest growth during the forecast period. Hospitals and clinics serve as a crucial driving force in the market, with several factors interrelating to propel market growth. High procedure volume stems from the diverse range of diagnostic and interventional procedures performed within facilities. This volume creates a consistent demand for ultrasound needle guides.
 

Additionally, hospitals and clinics are equipped with advanced imaging facilities, including ultrasound machines, which are extensively utilized for procedures such as ultrasound-guided biopsies. This reliance on ultrasound technology drives the need for needle guides to ensure accurate and precise needle placement. Further, increasing disposable spending in developed nations will contribute considerably towards the adoption of ultrasound needle guides in hospitals thereby leading to segment expansion.
 

U.S. ultrasound needle guides market accounted for USD 97 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. Increasing geriatric population base along with the rising incidence of cancer in the country will drive the U.S. market trends. For instance, as per the American Cancer Society, in 2021, it was estimated that over 1.9 million new cancer patients were diagnosed and around 608,570 cancer patient’s deaths in the U.S. Thus, the rising prevalence rate of numerous chronic disorders will contribute to the market revenue.
 

 Moreover, growing awareness regarding remote patient monitoring devices for improved accuracy, portability, connectivity, and user-friendly interfaces will boost the market adoption rate. The increasing number of surgical procedures, advancements in technology, and the strong presence of industry players are few factors are estimated to boost overall market share.
 

 Ultrasound Needle Guides Market Share

Some of the eminent market participants operating in the ultrasound needle guides market include

• Siemens Healthineers
• CIVCO Medical Solutions
• Bard Access Systems (now part of BD)
• Cook Medical
• Biopsy Sciences
• Aspen Surgical
• CIVCO AIROS
• Veran Medical Technologies
• Innovative Trauma Care
• Besmed
• PBN Medicals

 These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
 

Ultrasound Needle Guides Industry News

• In April 2022, Audax Private Equity's investment in Aspen Surgical provided substantial support as Aspen pursued organic growth and pursued larger-scale acquisition opportunities. This investment played a crucial role in positioning Aspen as one of the leading global providers of single-use surgical products in acute care and surgical settings.
   
• In March 2021, Aspen Surgical expanded its portfolio of surgical disposables and patient and staff safety products in the acute care market through the acquisition of Bluemed Medical Supplies. The integration of BlueMed's offerings further strengthened Aspen's comprehensive range of products in these business areas.
   

 Ultrasound needle guides market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Type (USD Million & Units)

• Disposable needle guides
• Reusable needle guides

By Application (USD Million)

• Tissue biopsy
• Fluid aspiration
• Vascular access procedures
• Nerve block and regional anesthesia
• Others

By End-use (USD Million)

• Hospitals and clinics
• Ambulatory surgical centers
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Denmark
  • Poland
  • Sweden
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • New Zealand
  • Thailand
  • Vietnam
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Turkey